Background
==========

Naïve mature B cells in peripheral lymphoid organs respond to a variety of extracellular signals through the activation of signal transduction pathways initiated by the B cell antigen, pattern-recognition, cytokine and chemokine receptors. B cell responses to signaling depend on the combination of ligands present, and include activation, proliferation, migration, differentiation, isotype class switching, somatic hypermutation, anergy, and apoptosis \[[@B1],[@B2]\]. Once activated, B cells can also serve as antigen presenting cells that preferentially present antigens recognized by their specific BCR. In contrast, dendritic cells and macrophages present varied antigens that are acquired less specifically through phagocytosis, macropinocytosis and receptor-mediated endocytosis via pattern-recognition receptors such as the mannose receptor.

BCR-specific antigen processing and presentation is initiated by BCR-mediated signal transduction triggered by antigenic stimulation \[[@B3],[@B4]\]. Antigen is then internalized by receptor-mediated endocytosis and trafficked through endosomes for acidification and fusion with lysosomes containing pH-sensitive hydrolytic enzymes for antigen processing. Endolysosomes containing processed antigenic peptides fuse with Golgi-derived vesicles containing MHC class II molecules assembled with invariant chain (Ii). The CLIP fragment of Ii bound in the cleft of the class II aβ dimer is replaced by antigen-derived peptides and the complex trafficked to the cell surface through vesicle secretory pathways.

It is well known that B cell antigen processing and presentation mediated through the BCR far exceeds the efficiency of presentation of the same antigen by macrophages or dendritic cells \[[@B5]\]. The mechanism giving rise to this increased efficiency has not been fully determined but appears to be a unique aspect of BCR-mediated antigen capture and processing as opposed to changes in the basic antigen processing and presentation machinery \[[@B6]\]. One mechanism that may contribute to efficiency is accelerated trafficking of BCR/antigen complexes to Class II containing vesicles inside the cell \[[@B7]\]. However, the molecular mediators of this vesicle trafficking, especially those components uniquely involved in the highly efficient B cell antigen processing and presentation pathway, have remained largely unknown.

We analyzed a B cell microarray dataset comparing the responses of normal splenic B cells to 32 individual ligands. This study was designed to determine functionally important input signals to contribute to the understanding of normal B cell biology and differs from existing B cell microarray studies which largely compare normal B cells to B cell lymphomas to identify tumor-specific gene expression changes. By combining this gene expression microarray analysis with bioinformatics analyses and functional assays, we have identified a set of specific genes that appear to be involved in BCR-mediated antigen capture, vesicle function and vesicle trafficking during B cell antigen processing and presentation. These data provide a foundation for the molecular characterization of this important immunological process.

Results
=======

Microarray analysis of ligand-treated B lymphocytes
---------------------------------------------------

Purified B lymphocytes were treated in culture with 32 different ligands over a timecourse of 30 min, 1 hr, 2 hr, and 4 hr. A detailed description of the data set has been published \[[@B8]\]. Following filtering, normalization and SAM analysis, genes that were differentially expressed by each ligand in comparison with time-matched, untreated controls were identified. Of the 32 ligands, CD40L, LPS, and AIG caused the most gene expression changes, especially at the 4 hr timepoint (Figure [1B](#F1){ref-type="fig"}). Further analysis focuses on these three immunologically-important ligands. Categorical values of 1, -1, and 0 (representing significantly upregulated, downregulated, or unchanged) were used to group genes together based on their expression response patterns (Table [1](#T1){ref-type="table"}). Genes not differentially expressed under at least one treatment condition were omitted from further analysis. Based on 3 ligand combinations and a possibility of 3 outcomes for each ligand (1, -1, 0), there are a possible 3^3^or 27 gene clusters, with the (0, 0, 0) outcome excluded since only genes that were differentially expressed under at least one treatment condition were selected (26 possible gene clusters). In our dataset, we only observe 19 of these possible 26. A variety of different expression patterns were observed. For example, Gene Cluster \#1 contains genes that are upregulated by all three ligands, whereas Gene Cluster \#14 contains genes that are only upregulated in response to LPS.

CLASSIFI analysis links gene clusters to cellular physiology
------------------------------------------------------------

Microarray expression data can be full of experimental and biological noise, and many microarray probes are not well characterized. We developed a gene cluster classification method that circumvents these limitations and links biological function with gene expression patterns derived from microarray experiments. This method, termed CLASSIFI, uses Gene Ontology™ annotation to identify significant co-clustering of genes with similar biological properties, based on the postulate that genes involved in the same biological process would be coordinately expressed.

CLASSIFI utilizes the gene description database developed by the Gene Ontology™ (GO) Consortium \[[@B9]\] to reveal co-clustering of genes with similar biological properties. The GO annotates gene products with GO terms based upon their molecular function, biological process, and cellular component. These descriptive terms are structured in a directed acyclic graph of parent-child relationships, allowing a term to have multiple parents \[[@B10],[@B11]\]. GO gene annotation has also been used by other groups as a tool for identifying biological processes relevant to gene expression profiling experiments \[[@B11]-[@B13]\].

CLASSIFI measures the probability of co-clustering for every gene ontology term designated to every gene in each gene cluster. Gene expression data clustering and gene cluster membership assignment generates the CLASSIFI input file (See [Additional file 1](#S1){ref-type="supplementary-material"}). CLASSIFI captures all of the GO terms annotated to every probe and then calculates the probability of chance co-clustering of GO terms. The final CLASSIFI output is a list of every GO term, ranked within each gene cluster from lowest to highest probability (See [Additional file 2](#S2){ref-type="supplementary-material"}).

The filtered data set contained 2545 probes, which led to the calculation of 5036 probabilities (See [Additional file 3](#S3){ref-type="supplementary-material"}). The GO term with the lowest probability for each gene cluster is shown in Table [1](#T1){ref-type="table"}. A significance cutoff of 1 × 10^-5^was established using a Bonferroni correction with an *alpha*of 0.05 and an *n*of 5036 (see \[[@B14]\] and references therein). Six gene clusters give rise to GO terms with significant probabilities: Gene Cluster \#1, 6, 7, 8, 14, and 18. Gene clusters identified by CLASSIFI to give significant probabilities exhibit predictable expression patterns that could be explained biologically, including gene clusters characterized by ligand-specific expression induction. Experimental noise may contribute to gene clusters with insignificant probabilities that show unusual expression patterns.

CLASSIFI results for some gene clusters are expected based on our current understanding of B cell physiology. For example, the GO term giving the lowest probability in Gene Cluster \#1 is \"nucleus\". This gene cluster represents genes which are upregulated in response to all three ligands: AIG, CD40L, and LPS, and includes genes involved in transcription, replication and RNA processing. All three of these ligands induce cellular activation \[[@B1],[@B2],[@B15]\] and proliferation (data not shown), so we would expect these kinds of nuclear genes to be highly expressed in B cells stimulated with all three ligands. The GO term giving the lowest probability in Gene Cluster \#6 is \"oxidoreductase activity, acting on NADH or NADPH\". It has recently been shown that stimulation through CD40 and other TNF family members results in the production of reactive oxygen species through NADPH \[[@B16]\]. Importantly, many of the GO terms giving the low probabilities in a given gene cluster are functionally related, e.g. monovalent inorganic ion transport, ion transport, transporter activity, and cation transport in Gene Cluster \#18 (Table [2](#T2){ref-type="table"}).

Experimental validation of CLASSIFI-derived biological predictions
------------------------------------------------------------------

CLASSIFI analysis should be viewed as a hypothesis-generating tool. While the statistical analysis is compelling, predictions that derive from the hypotheses should be verified experimentally. We were particularly interested in the AIG-specific Gene Cluster \#18 because these genes represent biological processes that are unique to antigenic stimulation rather than the general activation responses induced by all three ligands. The GO term giving the lowest probability in Gene Cluster \#18 is \"monovalent inorganic cation transport\" (GO:0015672). An examination of the genes annotated with this GO term revealed multiple components of the vacuolar ATPase H+ pump (Table [3](#T3){ref-type="table"}). Since stimulation through the BCR induces internalization of the receptor-antigen complex and trafficking through the endocytic system, \"monovalent inorganic cation transport\" could reflect the acidification of vesicles as they progress from endosomes to lysosomes during endocytosis. This AIG-specific cluster also contained an overrepresentation of genes involved in general \"transporter activity\" (GO:0005215), which includes genes like Rab9, sorting nexin 5 (Snx5) and N-ethylmaleimide sensitive fusion protein attachment protein alpha (Napa) that are involved in endosome trafficking and vesicle fusion. These observations led us to consider the hypothesis that AIG might induce the expression of various components of the endocytic and vesicle transport pathways in a manner that is independent of its effects on the general metabolic activation and proliferation of B cells, and that this might be part of a B cell-specific antigen processing and presentation function.

To ensure that the genes identified through the CLASSIFI analysis were meaningful, we first sought to verify their differential expression patterns. The microarray expression pattern of nine probes recognizing \"transporter activity\" genes in unstimulated and ligand-stimulated samples were evaluated (Figure [2A](#F2){ref-type="fig"}). In every case, expression of these genes was similar in all treatment conditions at 0.5 and 1 hr, but was higher in the AIG-treated samples at 2 hr and 4 hr. Examples in which the same gene is represented by two different probes show closely similar expression patterns, indicating the high quality of this microarray data set. To verify the ligand-specificity of expression, RT-PCR was used to examine the expression of a subset of these genes in independently-generated samples. Again, AIG induced enhanced expression of each of these genes compared to LPS and anti-CD40 (Figure [2B](#F2){ref-type="fig"}). RT-PCR results consistently confirm microarray expression data in this data set \[[@B8]\].

CLASSIFI analysis is based on the postulate that genes involved in the same biological process are coordinately expressed. Thus, one prediction of this analysis is that other genes involved in the same biological process that were not included in the microarray probe data set would show the same expression pattern. We evaluated 4 such genes that encode ATPase H+ pump complex subunits by RT-PCR. All of these genes demonstrated a preferential upregulation in response to AIG (Figure [2C](#F2){ref-type="fig"}). These data not only provide experimental validation of the CLASSIFI approach to microarray data analysis, but also further supports the hypothesis that AIG induces vesicle processing and transport as a biological process.

In order to further test predictions that follow from the CLASSIFI analysis we sought to determine if the process of endocytosis is activated in a ligand/receptor-specific manner. An internalization assay was performed in which the BCR is fluorescently labeled with a non-stimulating anti-IgM-FITC antibody prior to AIG treatment. After allowing time for internalization, the cells are subjected to an acid wash to remove surface-bound label. Label that has been internalized is protected from the acid wash and can therefore be detected using flow cytometry. Using this method, we found that BCR internalization (arrow, Figure [3D](#F3){ref-type="fig"}) occurs with AIG stimulation, but not CD40L or LPS stimulation in WEHI-231 cells (Figure [3A, G](#F3){ref-type="fig"}). Substantial internalization was found as early as 15 minutes post-stimulation and continued past 4 hours. Using fluorescence microscopy, internalized BCR can be seen in AIG-treated cells by 10 minutes. No internalization of the BCR is detected with anti-CD40 or LPS treatment (Figure [3J](#F3){ref-type="fig"}). Ligand-specific internalization of the BCR was also detected in primary B cells (data not shown).

To test whether receptor internalization following AIG stimulation is specific to the BCR and not other cell surface receptors, we performed internalization assays in which TLR4 (Toll-Like Receptor 4 -- the LPS receptor) or CD40 was labeled prior to AIG treatment. In both cases, no internalization of the labeled receptor was detected (Figure [3E, F](#F3){ref-type="fig"}), demonstrating that AIG induces specific internalization of the BCR. (The slight shift in CD40 staining probably results from the upregulation of CD40 in response to AIG treatment.) Finally, to test whether stimulation of TLR4 with LPS or CD40 with anti-CD40 induces TLR4 or CD40 internalization, we fluorescently labeled TLR4 or CD40, then treated cells with the corresponding ligands. In the case of TLR4 stimulation with LPS, no internalization is detected (Figure [3B](#F3){ref-type="fig"}). Anti-CD40 stimulation induces a rapid receptor shedding phenomenon \[[@B17]\] and so it is difficult to directly compare the results of these samples with the other treatment conditions. However, no evidence for internalization was found (Figure [3I](#F3){ref-type="fig"}). Thus, AIG induces a ligand-specific, receptor-specific endocytic process that is likely designed to capture specific antigen for processing and presentation.

Finally, MHC class II expression would be expected to be high in B cells undergoing antigen processing and presentation. We found that following overnight stimulation with anti-IgM, CD40L, and LPS, Class II expression on anti-IgM treated cells is sustained, while in CD40L and LPS treated cells Class II expression is significantly downregulated (Figure [4](#F4){ref-type="fig"}). This ligand-specificity for maintenance of Class II on the surface of anti-IgM-treated cells is interesting because it suggests that B cells constitutively express a high level of Class II on the cell surface in anticipation of antigen presentation, which is then down-regulated in stimulated cells unless they are stimulated through the BCR. This idea that B cells are primed to undergo antigen processing and presentation supports observations in the literature that antigen processing and presentation is accelerated with BCR stimulation. Further, our preliminary data indicate that B cells show enhanced stimulation of antigen-specific T cell clones in response to BCR stimulation (data not shown).

Discussion
==========

CLASSIFI analysis
-----------------

In this paper we report the analysis of gene expression responses of B lymphocytes to a panel of extracellular ligands using CLASSIFI, a statistical approach that uses GO annotation to identify significant co-clustering of related genes, thus linking biological function with gene expression patterns derived from microarray experiments. CLASSIFI circumvents two traditional limitations associated with microarray expression analysis -- the effects of experimental and biological noise, and the variable depth of knowledge of individual genes in the probe set. A well-characterized gene has relatively precise annotations that reach deep into the GO hierarchy, while a poorly-characterized gene is only annotated with high level terms. By capturing the entire ontology parentage of each gene, CLASSIFI overcomes limitations associated with variable depth-of-knowledge associated with most gene sets. In addition, the probability calculation used in CLASSIFI is relatively robust to the addition of experimental noise, allowing the use of less stringent data filtering approaches, which reduces the false negative discovery rate without the usual associated increase in false positives. Indeed, increasing the SAM FDR followed by CLASSIFI analysis increase the number of endocytosis-related genes while maintaining similar gene cluster classifications (data not shown).

Our analysis focused on the AIG-specific Gene Cluster \#18, which was statistically classified as an intracellular transport-related gene cluster. Inspection of the entire gene list leads to the hypothesis that Gene Cluster \#18 classification reflects the broader biological process of BCR-mediated endocytosis, vesicle acidification and trafficking, and antigen processing and presentation. CLASSIFI should be considered a hypothesis-generating tool that requires experimental validation. Several predictions of our hypothesis were confirmed experimentally, including ligand-specific endocytosis induction and MHC class II expression.

It should be noted that although we have used gene ontology annotation as a means of gene classification, any gene description scheme of interest could be used with the CLASSIFI approach to link experimental variables with legacy knowledge through gene expression microarray data.

Identification of putative components of BCR-mediated antigen capture, processing, and presentation (see Table [4](#T4){ref-type="table"} for reference to this section)
------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Based on the genes responsible for Gene Cluster \#18 classification (Table [3](#T3){ref-type="table"}), we hypothesized that BCR engagement activates receptor-mediated endocytosis, vesicle acidification, vesicle trafficking, and antigen processing and presentation. We manually curated the AIG-specific cluster gene list and found a total of 38 genes, including those identified using CLASSIFI, that might be involved based on the molecular functions defined in other cell systems and biological processes from the literature (Table [4A](#T4){ref-type="table"}). Figure [5](#F5){ref-type="fig"} shows a schematic representation of the B cell antigen processing and presentation pathway indicating the putative roles played by these genes.

Several genes known to be involved in signal transduction were found in Gene Cluster \#18; some have been demonstrated to play a role in BCR signaling while others are involved in signaling pathways in other cell types and are candidates for new BCR signaling components that stimulate the endocytic process (Table [4A](#T4){ref-type="table"}). Activation of protein kinases, including members of the MAP kinase family, in response to BCR engagement is well documented; thus Strap, Map4k1 (Hpk1) and Map2k3 may also play a role in BCR signaling. Indeed, Map4k1 is expressed in hematopoietic cells and is required for activation-induced T cell death following TCR stimulation, and Map2k3 is required for IL-12 production by macrophages and dendritic cells, and antigen-mediated activation of T cells. CD72 has been found to regulate the cellular response to BCR signaling either through the recruitment of the SHP-1 phosphatase thereby dampening BCR signaling, or by cooperating with BCR signaling to prevent apoptosis in immature B cells. The Dusp14 dual specificity phosphatase has been found to associate with the CD28 co-receptor and dampen TCR-mediated signaling in T cells by inactivation of MAP kinases, suggesting that it may regulate BCR signaling in a similar fashion. Daam1 is involved in Wnt signaling in Xenopus embryogenesis. Strap binds to the TGF beta type I receptor and inhibits downstream signaling. Whether these proteins might play a role in regulating BCR signaling remains to be determined. The NF-ATc2 isoform has been found to participate in the BCR-induced apoptosis in B-cell-derived Burkitt\'s lymphoma cell lines, thus the presence of Nfatc2ip and Fkbp1 suggests that these interacting proteins may also be important in regulating Ca^++^/calmodulin/calcineurin/NFAT signaling in B cells.

A large proportion of genes in Gene Cluster \#18 encode proteins with roles in endocytosis, vesicle trafficking, vesicle acidification, molecular processing and protein secretion. In most cases these roles have been defined in other cell systems. Since little is known about the molecular details of these processes in receptor-mediated antigen capture and MHC class II-dependent antigen processing and presentation in B cells, the possibility that Gene Cluster \#18 has produced a putative list of proteins that coordinate these activities is intriguing.

Snx5, a member of the sorting nexin family, has been found to interact with clathrin in skeletal muscle. Clathrin has been implicated in facilitating membrane invagination during receptor-mediated endocytosis in B cells. The presence of Snx5 in this cluster suggests that it may help mediate this process. The Als2 protein acts as a guanine nucleotide exchange factor for Rab5 and Rac1, and stimulates early endosome fusion. Rab proteins are small GTPases with homology to Ras that play key roles in vesicle transport: Rab18 has been found to localize near the apical and basolateral plasma membrane in epithelial cells of the kidney and intestine and Rab22a has been found to localize to the plasma membrane and early endosomes. Iqgap1 is a scaffolding protein with multiple protein-protein interaction domains and a GTPase activation protein (Gap) domain that stimulates the hydrolytic activity of Ras family members. Iqgap1 has also been found to localize to areas of membrane ruffling and newly formed vesicles in astrocytoma cells.

Genes encoding homologs to several components of the vesicle-type proton pump were found in Gene Cluster \#18, including Atp6v0b, Atp6v1g1, Atp6v1c1, and Atp6v1f and the proton pump accessory protein Atp6ap2. Additional proton pump components were also found to be induced in an AIG-specific manner by RT-PCR (Atp6v0c, Atp6va1, Atp6v1h and Atp6v1a1). Together with the vesicle-specific chloride channel Clcn7, these proteins are likely to play a role in the acidification of the endocytic vesicles in preparation for their fusion with lysosomes to facilitate antigen hydrolysis. Proton pump components can serve as a membrane anchor point for SNARE proteins. Napa appears to mediate the tethering of these vesicles in preparation for fusion. Rab9 also appears to play a role in vesicle fusion since mutations in Rab9 lead to the accumulation of lipid-rich vesicles.

Several proteins involved in lysosome formation and antigen processing were found in Gene Cluster \#18. Dysbindin binds to dystobrevins and is a component of the biogenesis of lysosome-related organelles complex 1 in mouse liver, which regulates trafficking to lysosomal organelles. Mutations in the Cln3 gene leads to a lysosomal storage disorder associated with the accumulation of lipopigment-laden vesicles. Hexosaminidase A is a pH-sensitive hydrolase. A variety of cathepsins are involved in MHC Class II antigen processing and presentation. None of the probes for these genes passed our data filtering process, however the cathepsin inhibitor Cystatin B was found in Gene Cluster \#18, suggesting that it might play a role in regulating cleavage site selection by modifying the relative activities of proteases involved in antigen processing and peptide loading. Hspbp1 may facilitate antigen processing by regulating the chaperone function of Hsp70, which has been associated with the presentation of myelin basic protein though MHC class II in multiple sclerosis.

Several genes involved in MHC class II expression were found in the AIG-specific gene cluster. Atf1 is a transcription factor that activates the promoter of the class II *trans*-activator (CIITA). Translocation of nascent MHC class II peptide chains into the lumen of the endoplasmic reticulum involves the function of the Sec61 translocation complex, the signal sequence receptor Ssr1 (a.k.a. TRAP alpha) and the signal peptidase SPC22. Calmegin (Clgn) is a Ca^++^binding chaperone protein with significant homology to calreticulin and calnexin, an ER chaperone protein that regulates the assembly of MHC class II with the Ii invariant chain.

Vesicles containing peptide-loaded MHC class II are transported to the plasma membrane for fusion and exposure on the cell surface, perhaps by traveling back through the TGN into the secretory pathway. The Vsp29 protein has been found to facilitate this kind of retrograde TGN transport in yeast. In neurons, reticulon 3 is associated with synaptophysin in tubulovesicular structures and may play a role in the process of vesicle secretion. CD63, an MHC class II co-receptor, may play a role in regulating MHC receptor compartmentalization.

38 genes found in Gene Cluster \#18 encode proteins that have some connection with signaling, antigen capture, vesicle transport, vesicle acidification or MHC class II expression, suggesting that activation of B cells through the BCR is inducing the expression of genes involved in MHC class II antigen processing and presentation. The activation of class II presentation by antigen receptor engagement in B cells has been described extensively. The findings reported here are novel in that microarray results combined with CLASSIFI analysis have provided a list of genes that may be involved in this important immunological process.

Finally, it is intriguing to note the presence of genes involved in the regulation of apoptosis and autoimmunity (Table [4C](#T4){ref-type="table"} and [4D](#T4){ref-type="table"}) in Gene Cluster \#18, given the known function of the BCR in negative selection and the induction of autoimmunity.

Transcriptional positive feedback
---------------------------------

The changes in mRNA levels for these genes involved in vesicle trafficking might be necessary to stimulate this biological process in AIG-stimulated B cells. However, the kinetics of the mRNA changes compared with the rapid induction of endocytosis suggests that this may not be the case. Elevated mRNA levels for these genes was found at 2 and 4 hr, but not at 0.5 or 1 hr post-stimulation. However, BCR endocytosis was maximally stimulated by 15 minutes. The rapid induction of endocytosis suggests that at least the initiation of this process is activated through post-transcriptional mechanisms. This finding suggests that the AIG-specific transcriptional reprogramming observed in response to BCR stimulation may reflect positive feedback regulation in which expression of proteins that have already been activated is increased either as a means to amplify or sustain the process. Perhaps components of this important biological process are present at low levels in resting cells, and levels increase in response to appropriate environmental cues. This kind of regulatory process might allow cells to respond rapidly to a broad set of variables in their changing environment while conserving energy and materials while in a resting state.

Conclusion
==========

In this paper, we describe a bioinformatics analysis of a B cell microarray dataset using CLASSIFI to determine the biological significance of microarray gene clusters defined by ligand-specific B cell responses. Importantly, results from laboratory experimentation support the hypotheses derived from this microarray data mining exercise. This work is a model for immunologists and other biologists for utilizing the growing field of bioinformatics for microarray data mining, hypothesis generation and hypothesis testing. Furthermore, the results from this analysis provide a foundation for a more detailed understanding of the B cell antigen processing and presentation pathway.

Methods
=======

Primary B cell isolation and culture
------------------------------------

Isolation of primary splenic murine B cells was performed as described in the Alliance for Cellular Signaling (AfCS)/Nature Signaling Gateway website \[[@B18]\]. Briefly, splenocytes from 6--10 week old C57BL/6 mice were subjected to a magnetic bead negative selection procedure (Miltenyi Biotech, Auburn, CA) to remove CD43+ and Mac-1+ cells, resulting in an enriched population of resting B cells that was an average of 96% B220+, as determined by flow cytometry \[[@B19]\]. Purified B cells were cultured in supplemented Iscove\'s Modified Dulbecco\'s Medium \[[@B20]\] with 100 U/ml penicillin and 100 μg/ml streptomycin (Invitrogen, Carlsbad, CA) at 37°C under 5% CO~2~. For microarray and internalization experiments, cells were treated for 0.5 hr, 1 hr, 2 hr, and 4 hr with media alone, or with mu chain specific Goat anti-mouse immunoglobulin, (AIG) (Jackson Immunoresearch) at 45 μg/ml, hamster anti-mouse CD40 monoclonal antibody, clone HM40-3 (BD Pharmingen) at 9.73 μg/ml, or lipopolysaccharide (LPS) (Sigma-Aldrich) at 40 μg/ml. For real-time PCR experiments, cells were treated with anti-IgM at 20 μg/ml or anti-CD40 at 625 ng/ml.

Microarray analysis and clustering
----------------------------------

Microarray-related experimental protocols can be found at the AfCS/Nature website at \[[@B21]\]; protocol IDs are: PP00000009-RNA extraction, PP00000019-sample preparation and hybridization. Briefly, RNA samples isolated from B cells treated with a panel of 32 ligands were compared with untreated samples using a microarray chip containing 15,494 cDNA probes printed on 15,832 spots representing 10,615 unique MGI gene matches (as of 12/31/03). 38% of the probes have not been assigned a gene name, 96% come from the RIKEN FANTOM collection, 3% from the Minoro Ko National Institute of Aging collection, and the rest from the Research Genetics and Genome Systems collections. RNA samples were used to generate Cy5- and Cy3-labeled cDNA targets (from sample RNAs and RBC-depleted total splenocyte RNA, respectively) and were hybridized together. All samples were run in triplicate except for 1 hr and 4 hr untreated controls, which were run in quadruplicate. Arrays were scanned using the Agilent Scanner G2505A (Agilent Technologies, Palo Alto, CA). Image files were analyzed using the Agilent G2566AA Feature Extraction software version A.6.1.1. The raw data from these experiments is available at \[[@B22]\]. Spot features on each array were filtered to remove those values that were saturated, non-uniform, or below background. Statistical filtering was accomplished using Significance Analysis of Microarrays (SAM) \[[@B23]\]. Features found by SAM to be differentially expressed between samples and time-matched untreated controls at a false discovery rate (FDR) of 1% were included for further analysis. Input for SAM were background-subtracted, dye bias- and interarray variance-normalized Cy5 fluorescence intensity values, which represent expression level of array features. Only features with more than two replicates were used in the SAM analysis. 100 random permutations were done for each comparison of treated to time-matched control samples. Values of +1, -1, or 0 were given to genes that were found by SAM to be significantly upregulated, downregulated, or unchanged (respectively) compared to time-matched untreated controls. These values were used to categorically group genes together based on their expression response patterns.

CLASSIFI analysis
-----------------

*Cl*uster *Assi*gnment for Biological *I*nference (CLASSIFI) was developed as a method for statistical evaluation of Gene Ontology™ (GO) term co-clustering (Figure [1A](#F1){ref-type="fig"}). CLASSIFI is predicated on the postulate that genes involved in the same biological process are coordinately expressed; examples of coordinate expression of interacting proteins in eukaryotes has been described \[[@B24]-[@B27]\]. Following data transformation, filtering, normalization, standard expression clustering approaches and gene cluster membership assignment, the following steps are performed in the CLASSIFI analysis: 1) remove duplicate probe IDs, 2) extract the primary GO annotations for each gene from a probe database, 3) capture the full GO ancestry for each primary GO annotation from the Gene Ontology™ database, and 4) calculate the solution for the cumulative hypergeometric distribution equation for every GO term in every gene cluster:

$P = 1 - {\sum\limits_{i = 0}^{n - 1}\frac{\begin{pmatrix}
f \\
i \\
\end{pmatrix}\begin{pmatrix}
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{c - i} \\
\end{pmatrix}}{\begin{pmatrix}
g \\
c \\
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where *g*= number of probes in the data set, *c*= number of probes in the gene cluster, *f*= number of probes with a given ontology in the data set, *n*= number of probes with a given ontology in the gene cluster. The hypergeometric distribution calculates the probability (*P*) that genes with a particular GO term would co-cluster by chance given the proportion of genes annotated with this GO term in the entire data set. A web interface for use of the CLASSIFI method with data derived from cDNA, oligonucleotide and Affymetrix microarrays, along with detailed information about CLASSIFI input and output files can be found at the CLASSIFI website \[[@B28]\].

Quantitative real-time reverse-transcription-polymerase chain reaction
----------------------------------------------------------------------

Total RNA was extracted as for the microarray experiments. 1 μg of total RNA was treated with DNaseI (Invitrogen), then reverse transcribed at 42°C for one hour in a 20 μl volume containing 1 μl MMLV reverse transcriptase (Invitrogen), 4 μl 5X buffer (Invitrogen), 0.5 mM dNTPs (Invitrogen), and 5 ng/μl pd(N)~6~(Amersham). Following inactivation at 70°C for 20 min, PCR reactions were set up in a 20 μl volume using Sybr Green Master Maker (Applied Biosystems). Thermal cycling began with a denaturation step of 10 minutes at 95°C, followed by 40 cycles of 95°C for 15 seconds (denaturation) and 60°C for 1 minute (annealing and extension). PCR reactions were performed in the ABI Prism 7700 Sequence Detector (PE Biosystems, Foster City, CA), and data collected and analyzed with the Sequence Detector software (PE Biosystems). Standard curves were generated using RNA isolated from RBC-depleted mouse splenocytes. RT-PCR of mouse 18S rRNA levels was used for normalization. Data from treated samples were compared to untreated samples, giving values representing the fold change in gene expression relative to untreated samples. PCR primers were designed using Primer3 software \[[@B29]\]: ATP6v0Bc\" forward (f) 5\'gaaccccagcctctttgtaa3\', reverse (r) 5\'cccatcttcactctggaggt3\'; ATP6v1c1 (f) 5\'tgcttgccaaagaggtaaca3\', (r) 5\'tcgctgcatgtagtttctcc3\'; sorting nexin V (f) 5\'gggagaaggggaaggatcta3\', (r) 5\'catgggtggacacagtcttc3\'; vacuolar protein 29S (f) 5\'ctgcagaggcagtttgatgt3\', (r) 5\'ggcagaacctgggttaatgt3\'; ATP6v0c (f) 5\'atgtcagtcatgaggccaga3\', (r) 5\'agcgataagtactgccacca3\'; ATP6v0a1 (f) 5\'tccacccagtctgtaggtga3\'. (r) 5\'atcatgatcagggtgcagaa3\'; ATP6v1h (f) 5\'gatgctgctgtcccaactaa3\', (r) 5\'agaaatcatctgcccctgaa3\'; ATP6v1a1 (f) 5\'gaattatgatgcgtccgatg3\', (r) 5\'cgcctgggatagcagtagtt3\'. Mouse 18S PCR primers sequences are from \[[@B30]\]: (f) 5\'gtaacccgttgaaccccatt3\', (r) 5\'ccatccaatcggtagtagcg3\'.

Internalization assays and flow cytometry
-----------------------------------------

1 × 10^6^WEHI-231 cells (a mouse B cell lymphoma line) were pre-stained for 10 min at 4°C with monoclonal antibodies to cell surface receptors: Rat anti-IgM-FITC clone R6-60.2 or clone II/40 (BD Pharmingen), Rat anti-CD40-FITC clone 3/23 (BD Pharmingen), or Rat anti-TLR4/MD2-PE clone MTS510 (eBiosciences). Following 2 washes in PBS/2% FBS/2 mM EDTA, cells were cultured and stimulated using the aforementioned ligand concentrations in RPMI supplemented with 10% FBS (Hyclone), 100 U/ml penicillin, 100 μg/ml streptomycin (Invitrogen, Carlsbad, CA), sodium pyruvate, HEPES, and 2-ME (Invitrogen). Following incubation at 37°C with 5% CO~2~for various time periods, cells were harvested and incubated at 4°C for 5 minutes in 0.2 M Acetic acid/0.5 M NaCl to strip off staining antibodies \[[@B31]\], or in PBS/2% FBS/2 mM EDTA (control). Following 2 washes in 0.2 M Acetic acid/0.5 M NaCl or PBS/2% FBS/2 mM EDTA, respectively, samples were fixed in 1% paraformaldehyde. Data were acquired using a FACSCalibur™ flow cytometer and analyzed using CellQuest™ software (Becton Dickinson Immunocytometry Systems).

MHC class II expression was measured by flow cytometric analysis using FITC-conjugated antibody against I-A^d^clone 39-10-8 (BD Pharmingen).

BCR localization by immunofluorescence microscopy
-------------------------------------------------

1 × 10^6^WEHI-231 cells were harvested and resuspended in 100 μl PBS containing 2% FBS. 2 μl of rat anti-IgM-FITC clone R6-60.2 antibody was added, and cells incubated on ice for 10 minutes to allow BCR staining. R6-60.2 was determined to be non-stimulating because it did not flux calcium or induce detectable tyrosine phosphorylation in these cells (data not shown). Following one wash in PBS/2%FBS, cells were resuspended in 100 ul phenol-red free growth medium (Invitrogen) and kept on ice prior to stimulation. Cells were stimulated by addition of ligands at the following concentrations: AIG, 20 μg/ml; HM40-3, 9.73 μg/ml; or LPS, 40 μg/ml. Images were captured at room temperature immediately following ligand stimulation for up to 10 min. Using the Zeiss Axioplan 2 upright fluorescence microscope (Carl Zeiss, Inc, Thornwood, NY), images were captured with the 60X objective under oil immersion using the OpenLab™ software, version 4.0.1 (Improvision, Boston, MA). 2 images were captured for each field of view: one for detection of FITC fluorescence, and one for differential interference contrast (DIC) imaging of cells. Images were processed using OpenLab™.
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S1P - Sphingosine-1-phosphate
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###### Additional File 1

**CLASSIFI input file**. The CLASSIFI input file was generated following microarray data clustering. It lists probe IDs, Gene names, and Cluster IDs resulting from categorical clustering of processed data from B cells stimulated with anti-CD40, LPS, and AIG. This input file was uploaded at the CLASSIFI website \[[@B28]\], which provides a web interface for the use of CLASSIFI.

###### 

Click here for file

###### Additional File 2

**CLASSIFI output file**. Complete output file resulting from CLASSIFI analysis of the data set. Clusterid = gene clusters resulting from categorical clustering of processed data from B cells stimulated with anti-CD40, LPS, and AIG. GO id = a unique Gene Ontology identifier that corresponds to a GO term, which is used to describe gene products based on molecular function, biological process, or cellular component. g = number of probes in the data set, f = number of probes with associated GO id in the data set, c = number of probes in the gene cluster, n = number of probes with associated GO id in the gene cluster. Expt = the expected number of occurrences of a given GO id in a given cluster of size (n) based on a random distribution. Prob = the probability that the GO id co-cluster pattern has occurred by chance.

###### 

Click here for file

###### Additional File 3

**CLASSIFI GO file**. Complete list of all GO ids (representing the entire GO ancestry) associated with each probe ID.

###### 

Click here for file
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Figures and Tables
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![**Experimental methodology and analysis of microarray data**. (A) Schematic of steps performed during microarray data processing. Gray boxes indicate steps performed as part of the CLASSIFI component of the analysis. See text for details. (B) The number of genes whose expression was significantly changed at the 4 hr timepoint as determined by SAM is shown for each of 32 ligands. Abbreviations and descriptions for each ligand can be found at \[22\]. 40L = CD40L (anti-CD40), LPS = Lipopolysaccharide, and AIG = anti-IgM.](1471-2105-7-237-1){#F1}

![**Expression data from select intracellular transport-related genes**. (A) Microarray results for expression patterns of several genes over a timecourse of 0.5 to 4 hr. The log~2~(Cy5/Cy3) values were compared to 0 hr untreated samples (t = 0). Three examples of genes represented by two different probes (probe Ids in parentheses) are shown in the two right columns. (B) Real-time RT-PCR analysis of four intracellular transport-related genes at 4 hours of stimulation that were included in the microarray data set. Data were normalized to mouse 18S rRNA as a reference and compared to untreated samples. ATP6v0bc\" and ATP6v1c1, n = 2. Sorting nexin V and Vacuolar protein 29S, n = 1. (C) Real-time RT-PCR analysis of 4 intracellular transport-related genes at 4 hours of stimulation that were not included in the microarray data set.](1471-2105-7-237-2){#F2}

![**Internalization of cell surface receptors in WEHI-231**. (A-I) Assay for internalization of BCR, CD40, and TLR4 was performed using WEHI-231 cells. Data from 1 hr stimulations are shown. Line thickness represents treatment of cells following labeling of receptor where thin = acid treated samples and thick = no acid treatment. Black = unstimulated, blue = LPS stimulated, red = AIG stimulated, green = anti-CD40 stimulated. Arrow denotes histogram of acid-treated cells in which labeled BCR is protected from the effects of acid treatment with AIG stimulation. (J) Localization of the BCR by fluorescence microscopy. BCR are labeled with a non-stimulating FITC-conjugated monoclonal anti-IgM antibody (green) and treated for 10 minutes as indicated. DIC images are shown in bottom row.](1471-2105-7-237-3){#F3}

![**Class II MHC expression in AIG, anti-CD40, and LPS stimulated WEHI-231**. Flow cytometric analysis of Class II I-A^d^expression in WEHI-231 in response to overnight stimulation with AIG (red), anti-CD40 (green), and LPS (blue) or media alone (thick black line). Thin black line represents the unstained control.](1471-2105-7-237-4){#F4}

![**Gene Cluster \#18 contains genes involved in several aspects of vesicle processing, intracellular trafficking, and antigen processing and presentation**. A manual curation of the gene list comprising Gene Cluster \#18 resulted in this detailed model of intracellular transport processes in B cells (refer to text for details). EE = early endosome, LE = late endosome, RE = recycling endosome, ELYS = endolysosome, LYS = lysosome, RER = endoplasmic reticulum, TGN = trans-Golgi network, NUCL = nucleus.](1471-2105-7-237-5){#F5}

###### 

Clustering and CLASSIFI results for data from 3 ligands

  GO ID        g      f      c     n    expt    prob       GO type   GO term                                             Cluster ID   anti-CD40   LPS   AIG
  ------------ ------ ------ ----- ---- ------- ---------- --------- --------------------------------------------------- ------------ ----------- ----- -----
  GO:0005634   2490   254    380   64   38.76   8.71E-06   CC        Nucleus                                             1            1           1     1
  GO:0009058   2490   141    180   25   10.19   1.36E-05   BP        biosynthesis                                        2            1           1     
  GO:0008372   2490   1409   1     1    0.566   5.66E-01   CC        CC unknown                                          3            1           -1    -1
  GO:0046072   2490   2      160   2    0.129   4.10E-03   BP        dTDP metabolism                                     4            1                 1
  GO:0009605   2490   30     3     2    0.036   4.18E-04   BP        response to external stimulus                       5            1                 -1
  GO:0016655   2490   14     331   11   1.861   4.94E-08   MF        oxidoreductase activity, acting on NADH             6            1                 
  GO:0005773   2490   12     11    4    0.053   1.00E-07   CC        Vacuole                                             7            -1          -1    1
  GO:0003779   2490   15     277   9    1.669   6.30E-06   MF        actin binding                                       8            -1          -1    -1
  GO:0016758   2490   6      245   4    0.59    1.17E-03   MF        Transferase activity, transferring hexosyl groups   9            -1          -1    
  GO:0006417   2490   2      4     1    0.003   3.21E-03   BP        regulation of protein biosynthesis                  10           -1                1
  GO:0008372   2490   1409   41    32   23.2    3.30E-03   CC        CC unknown                                          11           -1                -1
  GO:0008047   2490   10     160   3    0.643   2.23E-02   MF        enzyme activator activity                           12           -1                
  GO:0006397   2490   19     56    4    0.427   6.92E-04   BP        mRNA processing                                     13                       1     1
  GO:0005576   2490   156    183   33   11.47   7.28E-09   CC        extracellular                                       14                       1     
  GO:0046916   2490   1      4     1    0.002   1.61E-03   BP        transition metal ion homeostasis                    15                       -1    1
  GO:0003931   2490   3      38    2    0.046   6.74E-04   MF        Rho small monomeric GTPase activity                 16                       -1    -1
  GO:0004032   2490   3      188   3    0.227   4.24E-04   MF        aldehyde reductase activity                         17                       -1    
  GO:0015672   2490   10     191   7    0.767   1.38E-06   BP        monovalent inorganic cation transport               18                             1
  GO:0016892   2490   3      50    2    0.06    1.17E-03   MF        endoribonuclease activity, producing other than     19                             -1

Gene clusters (Cluster ID 1--19) resulting from categorical clustering of processed data from B cells stimulated with anti-CD40, LPS, and AIG. \"1\" = upregulated, \"-1\" = downregulated, and blank = no significant change. Following CLASSIFI analysis, the GO term giving rise to the lowest probability in each gene cluster is indicated. GO ID = a unique Gene Ontology identifier assigned to a GO term that corresponds to a defined molecular function (MF), biological process (BP), or cellular component (CC). g = number of probes in the data set, f = number of probes with associated GO ID in the data set, c = number of probes in the gene cluster, n = number of probes with associated GO ID in the gene cluster. Expt = the expected number of occurrences of a given GO ID in a given cluster of size (n) based on a random distribution. Prob = the probability that the GO ID co-cluster pattern has occurred by chance.

###### 

Excerpt of CLASSIFI results for six gene clusters giving significant probabilities

  GO ID        f     n    prob       GO type   GO term                                                                                     Cluster ID
  ------------ ----- ---- ---------- --------- ------------------------------------------------------------------------------------------- ------------
  GO:0005634   254   64   8.71E-06   CC        nucleus                                                                                     1
  GO:0005635   13    9    1.66E-05   CC        nuclear membrane                                                                            1
  GO:0006412   94    30   2.75E-05   BP        protein biosynthesis                                                                        1
  GO:0009059   94    30   2.75E-05   BP        macromolecule biosynthesis                                                                  1
  GO:0003743   20    10   2.68E-04   MF        translation initiation factor activity                                                      1
  GO:0016655   14    11   4.94E-08   MF        oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor   6
  GO:0008137   14    11   4.94E-08   MF        NADH dehydrogenase (ubiquinone) activity                                                    6
  GO:0015081   14    11   4.94E-08   MF        sodium ion transporter activity                                                             6
  GO:0016651   16    11   4.61E-07   MF        oxidoreductase activity, acting on NADH or NADPH                                            6
  GO:0046873   16    11   4.61E-07   MF        metal ion transporter activity                                                              6
  GO:0005773   12    4    1.00E-07   CC        vacuole                                                                                     7
  GO:0016787   163   6    2.52E-05   MF        hydrolase activity                                                                          7
  GO:0005624   15    3    2.84E-05   CC        membrane fraction                                                                           7
  GO:0000267   18    3    5.05E-05   CC        cell fraction                                                                               7
  GO:0015991   3     2    5.31E-05   BP        ATP hydrolysis coupled proton transport                                                     7
  GO:0003779   15    9    6.30E-06   MF        actin binding                                                                               8
  GO:0008092   22    9    3.08E-04   MF        cytoskeletal protein binding                                                                8
  GO:0003785   6     4    1.88E-03   MF        actin monomer binding                                                                       8
  GO:0006357   10    5    2.58E-03   BP        regulation of transcription from Pol II promoter                                            8
  GO:0006355   79    17   4.85E-03   BP        regulation of transcription, DNA-dependent                                                  8
  GO:0005576   156   33   7.28E-09   CC        extracellular                                                                               14
  GO:0005578   5     4    1.33E-04   CC        extracellular matrix                                                                        14
  GO:0004871   50    11   7.39E-04   MF        signal transducer activity                                                                  14
  GO:0004888   7     4    8.29E-04   MF        transmembrane receptor activity                                                             14
  GO:0007166   25    7    1.59E-03   BP        cell surface receptor linked signal transduction                                            14
  GO:0015672   10    7    1.38E-06   BP        monovalent inorganic cation transport                                                       18
  GO:0006811   23    10   2.65E-06   BP        ion transport                                                                               18
  GO:0005215   122   24   9.10E-06   MF        transporter activity                                                                        18
  GO:0006812   18    8    2.33E-05   BP        cation transport                                                                            18
  GO:0006754   4     4    3.36E-05   BP        ATP biosynthesis                                                                            18

The five GO IDs giving the lowest probability are listed for each of six gene clusters giving significant probabilities in Table 1. GO ID = a unique Gene Ontology identifier that corresponds to a defined molecular function, biological process, or cellular component (GO name). f = number of probes with the associated GO ID in the data set, n = number of probes with the associated GO ID in the gene cluster. prob = the probability that the GO ID co-cluster pattern has occurred by chance.

###### 

Genes annotated with transport-related GO terms from Gene Cluster \#18

  GO ID        Probe ID     Gene Name
  ------------ ------------ --------------------------------------------------------------------
  GO:0015672   C530010I21   ATPase, H+ transporting, V0 subunit B
  GO:0015672   2310069H14   ATPase, H+ transporting, V1 subunit G isoform 1
  GO:0015672   5730403E06   SIMILAR TO ATPASE, H+ TRANSPORTING, LYSOSOMAL
  GO:0006811   2810002O05   sideroflexin 1
  GO:0006811   1810048H22   arsA (bacterial) arsenite transporter, ATP-binding, homolog 1
  GO:0006811   2310021D14   chloride channel 7
  GO:0005215   1810011E08   MICROSOMAL SIGNAL PEPTIDASE 23 KDA SUBUNIT (EC 3.4.-.-)
  GO:0005215   2810433C04   translocase of inner mitochondrial membrane 9 homolog (yeast)
  GO:0005215   1500039N14   N-ethylmaleimide sensitive fusion protein attachment protein alpha
  GO:0005215   2210039G11   fatty acid binding protein 5, epidermal
  GO:0005215   5430437K12   zinc finger protein 295
  GO:0005215   1810057M21   thioredoxin reductase 1
  GO:0005215   2310004L13   translocase of inner mitochondrial membrane 9 homolog (yeast)
  GO:0005215   2610025H03   fatty acid binding protein 5, epidermal
  GO:0005215   5430413F24   RAB9, member RAS oncogene family
  GO:0005215   5830417J06   24-dehydrocholesterol reductase
  GO:0005215   0910001N05   sorting nexin 5
  GO:0005215   2410046L22   FK506 binding protein 1a
  GO:0005215   2010015D08   vacuolar protein sorting 29 (S. pombe)
  GO:0005215   3010014K12   N-ethylmaleimide sensitive fusion protein attachment protein alpha

List of characterized genes detected using specific cDNA probes (Probe ID) found in Gene Cluster \#18 that are associated with GO terms \"monovalent inorganic ion transport\" (GO:0015672), \"ion transport\" (GO:0006811), and \"transporter activity\" (GO:0005215). N.B. GO:0015672 is a child of GO:0006811, which is a child of GO:0005215 in the GO hierarchy.

###### 

Manual curation of Gene Cluster \#18 genes

      Protein description                                                             Gene Sym Symbol   LocusLink ID   Function                             Reference
  --- ------------------------------------------------------------------------------- ----------------- -------------- ------------------------------------ -----------
  A   CD72                                                                            Cd72              12517          BCR coreceptor                       32--34 35
      dual specificity phosphatase 14                                                 Dusp14            56405          lymphocyte signaling                 36
      mitogen activated protein kinase kinase kinase kinase 1                         Map4k1            26411          lymphocyte signaling                 37--39
      mitogen activated protein kinase kinase 3                                       Map2k3            26397          lymphocyte signaling                 40, 41
      serine/threonine kinase receptor associated protein                             Strap             20901          TGFbeta signaling                    42
      dishevelled associated activator of morphogenesis 1                             Daam1             208846         Wnt signaling                        43
      FK506 binding protein 1a                                                        Fkbp1a            14225          BCR signaling/apoptosis              44--46
      nuclear factor of activated T-cells, cytoplasmic 2 interacting protein          Nfatc2ip          18020          BCR signaling/apoptosis              44--46
      sorting nexin 5                                                                 Snx5              69178          endocytosis                          47, 48
      IQ motif containing GTPase activating protein 1                                 Iqgap1            29875          vesicle formation                    49, 50
      amyotrophic lateral sclerosis 2 (juvenile) homolog (human)                      Als2              74018          endosome fusion/Rab GEF              51, 52
      RAB18, RAS family                                                               Rab18             19330          endocytosis/vesicle recycling        53--56 56
      RAB22, RAS family                                                               Rab22a            19334          early endosome trafficking           56, 57
      Proton pump, subunit V0B (21 kDa)                                               Atp6v0b           114143         vesicle acidification                58--60
      Proton pump, subunit V1G1 (13 kDa)                                              Atp6v1g1          66290          vesicle acidification                58--60
      Proton pump, subunit V1C1 (42 kDa)                                              Atp6v1c1          66335          vesicle acidification                58--60
      similar to Proton pump, subunit V1F                                                               76610          vesicle acidification                58--60
      Proton pump accessory protein 2                                                 Atp6ap2           70495          vesicle acidification                61, 62
      Chloride channel 7                                                              Clcn7             26373          vesicle pH regulation                63, 64
      dystrobrevin binding protein 1 (dysbindin)                                      Dtnbp1            94245          lysosome formation                   65
      cystatin B                                                                      Cstb              13014          cathepsin protease inhibitor         66--68
      hexosaminidase A                                                                Hexa              15211          hydrolase                            69--71
      ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease)   Cln3              12752          lysosome function                    72
      HSP70 binding protein                                                           Hspbp1            66245          Ag processing/loading                73
      similar to HSPC135                                                                                66067          chaperone (?), GTPase (?)            
      HSPC245 homolog                                                                                                  chaperone (?)                        
      N-ethylmaleimide sensitive fusion protein attachment protein alpha              Napa              108124         vesicle fusion                       74, 75
      RAB9, RAS family                                                                Rab9              56382          vesicle tethering                    76, 77
      activating transcription factor 1                                               Atf1              11908          MHC expression                       78
      Sec61 alpha                                                                     Sec61a1           53421          ER translocation                     79
      signal sequence receptor, alpha                                                 Ssr1              107513         MHCII chaperone                      80
      calmegin                                                                        Clgn              12745          MHC chaperone                        81, 82
      similar to signal peptidase SPC22/23                                                              76687          secretory protein processing         83
      vacuolar protein sorting 29                                                     Vps29             56433          retrograde vesicle transport         84, 85
      reticulon 3                                                                     Rtn3              20168          exocytosis                           86, 87
      tubulin, alpha 6                                                                Tuba6             22146          cytoskeletal trafficking             88, 89
      CD63                                                                            Cd63              12512          MHCII coreceptor                     90--92
      source of immunodominant MHC-associated peptides                                Simp              68292          MHC peptide                          93
                                                                                                                                                            
  B   24-dehydrocholesterol reductase                                                 Dhcr24            74754          Cholesterol biosynthesis             94
      fatty acid binding protein 5, epidermal                                         Fabp5             16592          Fatty acid intracellular transport   95
      phosphatidylethanolamine binding protein                                        Pbp               23980          Membrane lipid transport             96
      prostaglandin D2 synthase 2, hematopoietic                                      Ptgds2            54486                                               
      peroxisome biogenesis factor 1                                                  Pex1              71382          Peroxisomal protein tranport         97
                                                                                                                                                            
  C   beclin 1 (coiled-coil, myosin-like BCL2-interacting protein)                    Becn1             56208          Tumor suppression                    98, 99
      caspase 4, apoptosis-related cysteine protease                                  Casp4             12363          Apoptosis                            100--102
      Cd27 binding protein (Hindu God of destruction)                                 Siva              30954          Apoptosis                            103, 104
                                                                                                                                                            
  D   polymyositis/scleroderma autoantigen 2                                          Pmscl2            50912          RNA processing autoantigen           105
      Sjogren\'s syndrome/scleroderma autoantigen 1 homolog (human)                   Sssca1            56390          centromeric autoantigen              106
      amyotrophic lateral sclerosis 2 (juvenile) homolog (human)                      Als2              74018          endosome fusion/Rab GEF              51, 52

Genes found in Gene Cluster \#18 with functions related to (A) intracellular trafficking, BCR signaling, vesicle processing and function, and antigen processing and presentation, (C) apoptosis, and (D) B cell-related autoimmune disease. (B) Genes annotated with \"transporter\" activity whose roles are not yet known to be associated with intracellular trafficking.
